Materials and Equipment Required

Before beginning, ensure the following materials and equipment are available:

• Recombinant Human Aggrecan Protein (SKU: rp365702, Aladdin Scientific)
• Sterile deionized water or phosphate-buffered saline (PBS, pH 7.4)
• Microcentrifuge tubes (1.5 mL, low-protein-binding recommended)
• Calibrated micropipettes and sterile tips
• Vortex mixer and microcentrifuge
• Ice bucket or cooling block
• -20 °C and/or -80 °C freezer for storage
• Protein quantification reagents (e.g., BCA or Bradford assay kit)
• Relevant downstream assay materials (e.g., ELISA kit, cell culture medium, binding assay buffers)

All procedures should be performed under aseptic conditions when the protein is intended for cell-based or in vitro functional assays.

Reconstitution Procedure

Follow the steps below to reconstitute Recombinant Human Aggrecan Protein:

1. Equilibrate the vial: Allow the lyophilized vial to equilibrate to room temperature (approximately 15–25 °C) for 10–15 minutes before opening to minimize condensation and protein loss.
2. Centrifuge the vial: Briefly spin the sealed vial (1,000–2,000 × g, 30 seconds) to collect lyophilized material at the bottom before opening.
3. Add reconstitution buffer: Add the appropriate volume of sterile deionized water or PBS (pH 7.4) as specified on the vial label. Gently pipette up and down — do NOT vortex vigorously, as this may denature the protein.
4. Incubate: Allow the reconstituted solution to sit at room temperature for 5–10 minutes to ensure complete dissolution.
5. Verify dissolution: Inspect visually for clarity. A slight opalescence may be acceptable; visible aggregates indicate incomplete dissolution — gently mix further or briefly warm to 37 °C for no more than 5 minutes.
6. Determine protein concentration: Measure protein concentration by BCA or Bradford assay to confirm the expected concentration matches the certificate of analysis (CoA) specification.
7. Aliquot for storage: Prepare single-use aliquots in low-binding tubes to avoid repeated freeze-thaw cycles.

Note: Always consult the product's Certificate of Analysis for lot-specific reconstitution volume and concentration data.

Storage and Stability Guidelines

Proper storage is essential to maintain the biological activity of Recombinant Human Aggrecan Protein:

• Lyophilized form: Store at -20 °C or -80 °C in a dry environment. Lyophilized protein is generally stable for up to 12 months from the date of manufacture when stored correctly. Refer to the CoA for the specific expiry date.
• Reconstituted protein: For short-term use (up to 1 week), store at 2–8 °C. For longer storage, prepare single-use aliquots and store at -20 °C or -80 °C.
• Avoid freeze-thaw cycling: Each freeze-thaw cycle can degrade protein integrity and reduce biological activity. Aliquoting prior to freezing is strongly recommended.
• Carrier protein addition: If the protein is not carrier-free, follow the CoA guidance. For carrier-free formulations used at low concentrations, adding 0.1% bovine serum albumin (BSA) as a stabilizer may be considered to reduce adsorption to tube surfaces.
• Do not store in frost-free freezers: Temperature cycling in frost-free freezers can accelerate protein degradation.

Review flag: Specific stability duration values should be verified against the product CoA provided by Aladdin Scientific for lot rp365702.

Experimental Application Guidelines

Recombinant Human Aggrecan Protein is suitable for a range of in vitro research applications. Common uses include:

• Cell-matrix interaction studies: Aggrecan can be used to coat culture surfaces or incorporated into hydrogel matrices to study chondrocyte adhesion, proliferation, and differentiation in a biomimetic extracellular matrix environment.
• Binding and interaction assays: Use in ELISA-based or surface plasmon resonance (SPR) assays to investigate interactions with hyaluronan, link protein, collagen, or other ECM components.
• Osteoarthritis and cartilage degradation models: Aggrecan can serve as a substrate for aggrecanase (ADAMTS) activity assays, enabling quantification of proteolytic cleavage as a model of cartilage catabolism.
• Western blot and immunoassay controls: Use as a positive control antigen in immunodetection experiments targeting aggrecan or its neo-epitopes.

Working concentration: Optimal working concentrations are application-dependent. Titration experiments are recommended to determine the concentration appropriate for your specific assay format. Typical ranges reported in the literature for proteoglycan coating assays are in the microgram-per-milliliter range; however, specific validated concentrations for rp365702 should be confirmed from the CoA or by empirical titration.

Endotoxin consideration: For cell-based assays, verify endotoxin levels from the CoA to ensure they are below thresholds that could confound biological responses.

Troubleshooting Common Issues

If unexpected results are obtained, consider the following troubleshooting steps: